Average Co-Inventor Count = 4.64
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Methylgene, Inc. (13 from 53 patents)
2. Merck Frosst Canada, Inc. (10 from 212 patents)
3. Astrazeneca Canada Inc. (6 from 14 patents)
4. Bellus Health Inc. (4 from 4 patents)
5. Bhi Limited Partnership (3 from 5 patents)
6. Merck + Co., Inc. (1 from 4,770 patents)
7. Astra Pharma Inc. (1 from 6 patents)
38 patents:
1. 11020360 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
2. 10857109 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
3. 10238611 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
4. 9499480 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
5. 8835654 - Method and compositions for treating amyloid-related diseases
6. 8748656 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
7. RE43343 - Inhibitors of histone deacetylase
8. 8088805 - Inhibitors of histone deacetylase
9. 8044100 - Methods and compositions for treating amyloid-related diseases
10. 7868204 - Inhibitors of histone deacetylase
11. 7838520 - Inhibitors of histone deacetylase
12. 7595343 - Inhibitors of histone deacetylase
13. 7312336 - Compounds with analgesic effect
14. 7288567 - Inhibitors of histone deacetylase
15. 7282608 - Inhibitors of histone deacetylase